| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating inflammatory pain and disease of the oral cavity, pharynx and larynx mucosa, comprising alpha-2 adrenergic receptor agonists. In another aspect, the present invention provides mucosal bioadhesive sustained release carriers for long-term and controlled release of alpha-2 adrenergic receptor agonists that can be used on mucosal surfaces to prevent or treat inflammatory pain and disease of the oral mucosa. To provide. |